<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttp://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 9/11/2007


Tuesday, September 11, 2007

September 11, 2007

FDA issues an FDA Alert and Healthcare Professional sheet for Rocephin
(ceftriaxone) clarifying concomitant use with calcium-containing
products or solutions. Drug Information
http://www.fda.gov/cder/drug/infopage/ceftriaxone/default.htm

New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Carvedilol Tablets, Hikma Pharma, Approval

Cefotaxime Injection and Dextrose Injection, B. Braun Medical, Inc.,
Labeling Revision

Cromolyn Sodium Nasal Solution, QPharma, Approval

Tricor (fenofibrate) Tablets, Abbott Labs, Labeling Revision

Zolpidem Tartrate Tablets, Invagen Pharma, Approval

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 4:25 PM,




0 Comments:

Post a Comment

<< Home